Sideris Pharmaceuticals

About:

Sideris Pharmaceuticals is focused on the development of therapeutics for the treatment of transfusion-related iron overload.

Website: http://www.siderispharma.com

Top Investors: MPM Capital, OUP (Osage University Partners), Hatteras Venture Partners

Description:

Sideris Pharmaceuticals Inc. is a privately held biopharmaceutical company that is focused on development of therapeutics for the treatment of transfusion-related iron overload. The company’s operations include facilities in Boston, MA, and in Gainesville, FL.

Total Funding Amount:

$32.6M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Lexington, Massachusetts, United States

Founded Date:

2012-01-01

Founders:

Raymond Bergeron, Thomas Neenan

Number of Employees:

11-50

Last Funding Date:

2013-10-22

IPO Status:

Private

Industries:

© 2025 bioDAO.ai